post-1

AIkido Pharma Inc. Announces Exercise of Option to Purchase Additional Shares in Bought Deal Offering

AIkido Pharma Inc. Announces Exercise of Option to Purchase Additional Shares in Bought Deal Offering

post-1

Artificial Intelligence Is Optimizing Drug Development

Artificial Intelligence Is Optimizing Drug Development

post-1

Manhattan Software Modifications To Your WMS From WynCore Help Improve Your WMS

Manhattan Software Modifications To Your WMS From WynCore Help Improve Your WMS

post-1

Aikido Pharma Focuses on The Treatment of Four Main Types of Cancer

Aikido Pharma Focuses on The Treatment of Four Main Types of Cancer

post-1

Dr Mary Clifton M.D. Offers Iowa Medical Marijuana Card Consultations To Iowa Residents

Dr Mary Clifton M.D. Offers Iowa Medical Marijuana Card Consultations To Iowa Residents

post-1

Findit Highlights Members Hip Hop Bling, ClassWorx and Dr. Mary Clifton Who Benefit From Findit Online Marketing Campaigns

Findit Highlights Members Hip Hop Bling, ClassWorx and Dr. Mary Clifton Who Benefit From Findit Online Marketing Campaigns

post-1

AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of Common Stock

AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of Common Stock

post-1

AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million

AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million

post-1

AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock

AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock

post-1

WynCore Customizes Manhattan Software For Warehouse Management Systems To Improve Warehouse Efficiency

WynCore Customizes Manhattan Software For Warehouse Management Systems To Improve Warehouse Efficiency

post-1

Aikido Pharma Announces Information on KPC-34 Which Was Developed at the Wake Forest School of Medicine

Aikido Pharma Announces Information on KPC-34 Which Was Developed at the Wake Forest School of Medicine

post-1

As COVID-19 Vaccines Continue To Get Distributed Global WholeHealth Partners Sources Premium PPE Supplies and Testing Kits

As COVID-19 Vaccines Continue To Get Distributed Global WholeHealth Partners Sources Premium PPE Supplies and Testing Kits

post-1

Lobe Sciences Retains Jolt Communications to Increase Investor Awareness

Lobe Sciences Retains Jolt Communications to Increase Investor Awareness

post-1

Aikido Pharma Establishes Licensing Agreement with University of Maryland
for Antiviral Compounds, Including COVID-19

Aikido Pharma Establishes Licensing Agreement with University of Maryland
for Antiviral Compounds, Including COVID-19

post-1

Global WholeHealth Partners Is The Preferred Supplier of Premium PPE Supplies and COVID-19 Diagnostic Testing Kits Available for Wholesale Purchase

Global WholeHealth Partners Is The Preferred Supplier of Premium PPE Supplies and COVID-19 Diagnostic Testing Kits Available for Wholesale Purchase

post-1

Dr. Mary Clifton of Iowa Helps Qualify Individuals For Their Iowa Medical Marijuana Card

Dr. Mary Clifton of Iowa Helps Qualify Individuals For Their Iowa Medical Marijuana Card

post-1

Chill N Out Cryotherapy Inc. Files Year End Financials for 2018 2019 and 2020 to Bring Company Current on OTC Markets

Chill N Out Cryotherapy Inc. Files Year End Financials for 2018 2019 and 2020 to Bring Company Current on OTC Markets

post-1

Dr. Mary Clifton Assists Individuals with Getting Medical Marijuana Cards in Iowa

Dr. Mary Clifton Assists Individuals with Getting Medical Marijuana Cards in Iowa

post-1

WynCore Offers The Best Manhattan Software Modifications for Warehouse Management Systems

WynCore Offers The Best Manhattan Software Modifications for Warehouse Management Systems

post-1

Aikido Pharma Secures Early Interest in Convergent Therapeutics, Inc. Who Focuses On Next Generation Radiopharmaceutical Therapy for Prostate Cancer

Aikido Pharma Secures Early Interest in Convergent Therapeutics, Inc. Who Focuses On Next Generation Radiopharmaceutical Therapy for Prostate Cancer